Page 28 - ARNM-2-2

Advances in Radiotherapy
& Nuclear Medicine Melanoma brain metastatic treatment

34. Murphy B, Walker J, Bassale S, et al. Concurrent radiosurgery 39. Nardin C, Mateus C, Texier M, et al. Tolerance and
and immune checkpoint inhibition: Improving regional outcomes of stereotactic radiosurgery combined with anti-
intracranial control for patients with metastatic melanoma. programmed cell death-1 (pembrolizumab) for melanoma
Am J Clin Oncol. 2019;42(3):253-257. brain metastases. Melanoma Res. 2018;28(2):111-119.
doi: 10.1097/COC.0000000000000509 doi: 10.1097/CMR.0000000000000413
35. Qian JM, Yu JB, Kluger HM, Chiang VLS. Timing and type 40. Yusuf MB, Amsbaugh MJ, Burton E, Chesney J, Woo S.
of immune checkpoint therapy affect the early radiographic Peri-SRS administration of immune checkpoint therapy for
response of melanoma brain metastases to stereotactic melanoma metastatic to the brain: Investigating efficacy and
radiosurgery. Cancer. 2016;122(19):3051-3058. the effects of relative treatment timing on lesion response.
World Neurosurg. 2017;100:632-640.e4.
doi: 10.1002/cncr.30138
doi: 10.1016/j.wneu.2017.01.101
36. Skrepnik T, Sundararajan S, Cui H, Stea B. Improved
time to disease progression in the brain in patients with 41. Martin AM, Cagney DN, Catalano PJ, et al. Immunotherapy
melanoma brain metastases treated with concurrent and symptomatic radiation necrosis in patients with brain
delivery of radiosurgery and ipilimumab. Oncoimmunology. metastases treated with stereotactic radiation. JAMA Oncol.
2017;6(3):e1283461. 2018;4(8):1123-1124.
doi: 10.1080/2162402X.2017.1283461 doi: 10.1001/jamaoncol.2017.3993
37. Le A, Mohammadi H, Mohammed T, et al. Local and distant 42. Koenig JL, Shi S, Sborov K, et al. Adverse radiation effect
brain control in melanoma and NSCLC brain metastases and disease control in patients undergoing stereotactic
with concurrent radiosurgery and immune checkpoint radiosurgery and immune checkpoint inhibitor therapy for
inhibition. J Neurooncol. 2022;158(3):481-488. brain metastases. World Neurosurg. 2019;126:e1399-e1411.
doi: 10.1007/s11060-022-04038-z doi: 10.1016/j.wneu.2019.03.110
43. Anvari A, Sasanpour P, Kheradmardi MR. Radiotherapy and
38. Lehrer EJ, Peterson J, Brown PD, et al. Treatment of brain
metastases with stereotactic radiosurgery and immune immunotherapy in melanoma brain metastases. Hematol
checkpoint inhibitors: An international meta-analysis of Oncol Stem Cell Ther. 2023;16:1-20.
individual patient data. Radiother Oncol. 2019;130:104-112. doi: 10.1016/j.hemonc.2021.11.001

Volume 2 Issue 2 (2024) 8 doi: 10.36922/arnm.3499